VIRX
Adage Capital Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-300,000
| Closed | -$477K | – | 948 |
|
|
2023
Q1 | $477K | Hold |
300,000
| – | – | ﹤0.01% | 818 |
|
|
2022
Q4 | $438K | Hold |
300,000
| – | – | ﹤0.01% | 862 |
|
|
2022
Q3 | $1.28M | Sell |
300,000
-170,000
| -36% | -$726K | ﹤0.01% | 880 |
|
|
2022
Q2 | $1.82M | Buy |
470,000
+216,309
| +85% | +$839K | ﹤0.01% | 887 |
|
|
2022
Q1 | $1.21M | Buy |
+253,691
| New | +$1.21M | ﹤0.01% | 928 |
|
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$200K | – | 767 |
|
|
2018
Q3 | $200K | Hold |
100,000
| – | – | ﹤0.01% | 706 |
|
|
2018
Q2 | $212K | Hold |
100,000
| – | – | ﹤0.01% | 725 |
|
|
2018
Q1 | $272K | Buy |
+100,000
| New | +$272K | ﹤0.01% | 711 |
|
|
2015
Q1 | – | Sell |
-778,300
| Closed | -$1.99M | – | 761 |
|
|
2014
Q4 | $1.99M | Buy |
+778,300
| New | +$1.99M | ﹤0.01% | 668 |
|
|
2014
Q1 | – | Sell |
-37,600
| Closed | -$178K | – | 743 |
|
|
2013
Q4 | $178K | Buy |
+37,600
| New | +$178K | ﹤0.01% | 673 |
|
|
2013
Q3 | – | Sell |
-150,000
| Closed | -$778K | – | 742 |
|
|
2013
Q2 | $778K | Buy |
+150,000
| New | +$778K | ﹤0.01% | 661 |
|